International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7951132
Original Article
Prone Versus Modified Supine Position in Percutaneous Nephrolithotomy: A Prospective Cohort Study
 ,
 ,
 ,
 ,
 ,
 ,
Published
May 19, 2023
Abstract
Aims and objectives: the present study was conducted to compare prone versus modified supine position in percutaneous nephrolithotomy. Material and methods: The present study is a prospective cohort study conducted in Department of Surgery in Gandhi Medical College and Hamidia Hospital, Bhopal from December 2020 to October 2022. All the patients presenting with renal calculi of size more than 1.5cm or less than 1.5cm with history of failed ESWL or retrograde lithotripsy were included in the study. Results and Conclusion: A total of 30 patients with a median age of 46 years were studied, 15 (50%) underwent PCNL in prone position and 15 (50%) in supine position. There were no significant differences in gender, age, body mass index, stone location, stone size and the presence of hydronephrosis between the two groups. Time from anaesthesia pre-medication to first attempt to puncture the kidney was significantly lower in supine groupas compared to the prone group (32.67mins vs 44.67mins, p<0.05).There was no significant difference in the outcome variables, namely, post-op hemoglobin, days of hematuria, VAS effort score, pain or length of hospital stay. Thus, Modified Supine position allows a reduction in the time needed to position the patient and in the effort sustained by professional nurses, if compared to the prone position. These benefit sallow an optimization of the available resources with economic implications.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
842 Views
296 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved